Hudson's Bipartisan Agriculture Legislation Signed into Law

August 15, 2018
Hudson’s Bipartisan Agriculture Legislation Signed into Law
Trump Signs Bipartisan Bill Reauthorizing Animal Drug & Animal Generic Drug User Fee Programs, Including Hudson’s Legislation
WASHINGTON, D.C. – Today U.S. Representative Richard Hudson (NC-08), Chairman of the Agriculture and Rural America Task Force, released the following statement after President Donald Trump signed into law the Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (H.R. 5554). This bill includes his legislation, the Animal Health and Innovation Act of 2018 (H.R. 5599), which will expand the innovative conditional approval pathway to major uses and major species, such as dogs, cats, horses, swine, and poultry.
“This is a big deal for our farmers,” said Rep. Hudson.“It gives them the tools they need to keep animals healthy while improving the gold standard we have for food safety. I want to thank President Trump for signing this important bill into law, and I’ll continue to work with him to support our farmers and rural communities.”
H.R. 5554 will amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs (Animal Drug User Fee Act or ADUFA) and new generic animal drugs (Animal Generic Drug User Fee Act or AGDUFA). H.R. 5554 passed the House on July 16, by voice vote. The bill passed the Senate on July 31, by unanimous consent.
Included in the reauthorization was an amendment by Rep. Hudson to expand conditional approval to major uses and major species so innovative veterinary drugs can help pets and livestock have a higher quality of life and prolonged lifespans. Currently, conditional approval allows certain animal drug products for unmet medical needs in minor uses and minor species to come to market on a conditional, year by year basis for up to five years to prove efficacy. Conditional approval is only granted to veterinary drug products that have been demonstrated to be safe to use and have a reasonable expectation of effectiveness. This pathway is critical in circumstances where there is unmet veterinary medical need, but a clinical efficacy trial is difficult to construct.
Current standards for major uses and major species require substantial evidence of efficacy in order to gain approval. Two examples, degenerative joint disease in dogs, cats and horses and Blackhead Disease in turkeys, paint the picture for why conditional approval is necessary for both companion animals and agricultural livestock. Degenerative joint disease is a crippling condition that develops over time in dogs, cats and horses. Currently, treatments exist to treat the pain and inflammation once the disease has presented itself, but there is no treatment to slow the progression of the disease. Because the disease develops slowly, it is almost impossible to collect the clinically required data necessary to demonstrate efficacy of a treatment that stops or slows the onset of the disease within a reasonable timeframe. Expanding conditional approval would allow collection of clinical efficacy data over time, creating opportunities for drug development.
Blackhead Disease is a random biological event that can wipe out an entire turkey flock within weeks, resulting in a devastating setback to any farmer across the country it strikes. Because Blackhead Disease is a random biological event, it is impossible to design a full scale clinical trial to gather the necessary data to prove efficacy. Expanding conditional approval would allow a drug that is proven safe to collect efficacy data when Blackhead Disease pops up, helping farmers save their flocks.
In 2004, Congress granted the Food and Drug Administration (FDA) the authority to conditionally approve drugs for minor uses and minor species through the Minor Use and Minor Species Animal Health Act of 2003. This law demonstrated the benefits of conditional use for veterinary medicine and FDA agreed in the March 18th hearing on Reauthorization of Animal Drug User Fees that expanding conditional approval to major uses and major species will help meet current unmet medical needs.
Rep. Hudson’s amendment will help companion pet owners and farmers gain access to innovative new treatments that will help save pets and livestock from hardship, pain and possible death.
  • Office Locations Push

    Office Name Location Image Map URL
    Washington, DC Office 2112 Rayburn House Office Building
    Washington, DC 20515
    Phone: (202) 225-3715
    Fax: (202) 225-4036
    Hours: M-F 8:30am-6:00pm
    Concord Office 325 McGill Avenue, NW
    Suite 500
    Concord, NC 28027
    Phone: (704) 786-1612
    Fax: (704) 782-1004
    Hours: M-F 8:30am-5:30pm
    Fayetteville Office 225 Green Street, Suite 202
    Fayetteville, NC 28301
    Phone: (910) 997-2070
    Fax: (910) 817-7202
    Hours: M-F 8:30am-5:30pm
    Pinehurst Office  Sandhills Community College
    Logan Building, Room 221
    3395 Airport Road
    Pinehurst, NC 28374
    (910) 246-5374
    Hours: Tues/Thurs 8:30am-5:30pm
    and by appointment
    Albemarle Office   Stanly County Commissioner's Office, Suite 9
    1000 N. First Street
    Albemarle, NC 28001
    Phone: (704) 786-1612
    Hours: Third Thursday of Every Month, 9:30am-12pm


    How to use: Insert <span class="EXACT_VALUE_LABEL_AS_ENTERED_BELOW">&nbsp;</span> where you'd like the value to be populated.

    Non-breaking space within span tags - &nbsp; - is required for WYSIWYG.

    (no spaces or special characters)


    Comments (optional)
    repName John Smith  
    helpWithFedAgencyAddress Haverhill District Office
    1234 S. Courthouse
    Haverhill, CA 35602
    district 21st District of California  
    academyUSCitizenDate July 1, 2012  
    academyAgeDate July 1, 2012  
    academyApplicationDueDate October 20, 2012  
    repStateABBR AZ  
    repDistrict 1  
    repState Arizona  
    repDistrictText 1st  
    SponsoredBills Sponsored Bills  
    CoSponsoredBills Co-Sponsored Bills  

Footer Survey

*By answering this survey, you are subscribing to my newsletter.